Terms: = Kidney tumors AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Prognosis
19 results:
1. Clear cell urothelial carcinoma of bladder: Case report of a rare and aggressive variant with review of literature.
Sahetia KM; Dave VN; Pal M; Menon S
Indian J Cancer; 2023 Oct; 60(4):575-577. PubMed ID: 38145907
[TBL] [Abstract] [Full Text] [Related]
2. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract] [Full Text] [Related]
3. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
4. Expression profile and prognostic values of GATA family members in kidney renal clear cell carcinoma.
Yang X; Mei C; Nie H; Zhou J; Ou C; He X
Aging (Albany NY); 2023 Mar; 15(6):2170-2188. PubMed ID: 36961416
[TBL] [Abstract] [Full Text] [Related]
5. Papillary renal cell neoplasm with reverse polarity: A new subtype of renal tumour with favorable prognosis.
Conde-Ferreirós M; Domínguez-de Dios J; Juaneda-Magdalena L; Bellas-Pereira A; San Miguel Fraile MP; Peteiro Cancelo MÁ; Gómez-de María C; Álvarez Sarria M; Betancor Santos MÁ; González-Carreró J; Ortiz-Rey JA
Actas Urol Esp (Engl Ed); 2022 Dec; 46(10):600-605. PubMed ID: 36216763
[TBL] [Abstract] [Full Text] [Related]
6. gata3 aids in distinguishing fumarate hydratase-deficient renal cell carcinoma from papillary renal cell carcinoma.
Liu Y; Dong Y; Gu Y; Xu H; Fan Y; Li X; Dong L; Zhou L; Yang X; Wang C
Ann Diagn Pathol; 2022 Oct; 60():152007. PubMed ID: 35841867
[TBL] [Abstract] [Full Text] [Related]
7. Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinoma.
Liu Y; Zhang H; Li X; Wang S; Zhang Y; Zhang X; Xu T; Dong Y; Dong L; Zhou L; Yang X; Wang C
Hum Pathol; 2022 Sep; 127():78-85. PubMed ID: 35724772
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA PVT1 is increased in renal cell carcinoma and affects viability and migration in vitro.
Bohosova J; Kasik M; Kubickova A; Trachtova K; Stanik M; Poprach A; Slaby O
J Clin Lab Anal; 2022 Jun; 36(6):e24442. PubMed ID: 35441392
[TBL] [Abstract] [Full Text] [Related]
9. [Papillary renal neoplasm with reverse polarity: a clinicopathological analysis].
Ji RH; Wang XT; Li R; Ye SB; Wang X; Ma HH; Lu ZF; Rao Q; Xia QY
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):23-27. PubMed ID: 34979749
[No Abstract] [Full Text] [Related]
10. ABCC2 expression in papillary renal cell carcinoma provides better prognostic stratification than WHO/ISUP nucleolar grade.
Saleeb RM; Brimo F; Gao Y; Boulos C; Kim SS; Al Bashir S; Husain A; Rotondo F; Beharry V; Bjarnason GA; Krizova A; Trpkov K; Yousef GM
Hum Pathol; 2022 Feb; 120():57-70. PubMed ID: 34958810
[TBL] [Abstract] [Full Text] [Related]
11. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity.
Kiyozawa D; Kohashi K; Takamatsu D; Yamamoto T; Eto M; Iwasaki T; Motoshita J; Shimokama T; Kinjo M; Oshiro Y; Yonemasu H; Oda Y
Hum Pathol; 2021 Jun; 112():48-58. PubMed ID: 33811832
[TBL] [Abstract] [Full Text] [Related]
12. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients.
Lau HD; Chan E; Fan AC; Kunder CA; Williamson SR; Zhou M; Idrees MT; Maclean FM; Gill AJ; Kao CS
Am J Surg Pathol; 2020 Jan; 44(1):98-110. PubMed ID: 31524643
[TBL] [Abstract] [Full Text] [Related]
13. Primary carcinosarcoma of the ureteropelvic junction associated with ureteral duplication: A case report.
Tsuji K; Ito A; Kurokawa S; Nakaya T; Yoshimoto T; Kawata H; Tamba-Sakaguchi M; Fukushima N; Oshiro H
Medicine (Baltimore); 2019 Aug; 98(32):e16643. PubMed ID: 31393362
[TBL] [Abstract] [Full Text] [Related]
14. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
[TBL] [Abstract] [Full Text] [Related]
15. [Comparative morphological characteristics and immunophenotype of urothelial carcinomas of the renal pelvis and bladder].
Osmanov YI; Gaibov ZA; Kogan EA; Radenska-Lopovok SG; Tursunov KZ
Arkh Patol; 2018; 80(5):23-32. PubMed ID: 30335057
[TBL] [Abstract] [Full Text] [Related]
16. gata3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma.
So JS; Epstein JI
Mod Pathol; 2013 Oct; 26(10):1365-70. PubMed ID: 23599157
[TBL] [Abstract] [Full Text] [Related]
17. [Roles of trichorhinophalangeal syndrome-1 gene in normal breast development and breast cancer].
Bao Y; Zhong ZX; Cui G; Guo L; Wang ZF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):121-4. PubMed ID: 23469802
[TBL] [Abstract] [Full Text] [Related]
18. Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer.
Chen JQ; Bao Y; Litton J; Xiao L; Zhang HZ; Warneke CL; Wu Y; Shen X; Wu S; Katz RL; Sahin A; Bondy M; Murray JL; Radvanyi L
Horm Cancer; 2011 Apr; 2(2):132-43. PubMed ID: 21761336
[TBL] [Abstract] [Full Text] [Related]
19. GATA-3 as a marker of hormone response in breast cancer.
Fang SH; Chen Y; Weigel RJ
J Surg Res; 2009 Dec; 157(2):290-5. PubMed ID: 19059610
[TBL] [Abstract] [Full Text] [Related]
